patient_id,superpopulation,n_variants_carried,primary_gene,severity_score,severity_category,predicted_progression,all_genes,pathway_Proteostasis,pathway_Proteostasis_score,pathway_Proteostasis_genes,pathway_Proteostasis_mechanisms,pathway_RNA_Metabolism,pathway_RNA_Metabolism_score,pathway_RNA_Metabolism_genes,pathway_RNA_Metabolism_mechanisms,pathway_Cytoskeletal_Axonal_Transport,pathway_Cytoskeletal_Axonal_Transport_score,pathway_Cytoskeletal_Axonal_Transport_genes,pathway_Cytoskeletal_Axonal_Transport_mechanisms,pathway_Mitochondrial,pathway_Mitochondrial_score,pathway_Mitochondrial_genes,pathway_Mitochondrial_mechanisms,pathway_Excitotoxicity,pathway_Excitotoxicity_score,pathway_Excitotoxicity_genes,pathway_Excitotoxicity_mechanisms,pathway_Vesicle_Trafficking,pathway_Vesicle_Trafficking_score,pathway_Vesicle_Trafficking_genes,pathway_Vesicle_Trafficking_mechanisms,pathway_DNA_Damage,pathway_DNA_Damage_score,pathway_DNA_Damage_genes,pathway_DNA_Damage_mechanisms,n_pathways_affected,primary_pathway,all_mechanisms,primary_gene_mechanism
AFR_00000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00002,AFR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00003,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00005,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00006,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00007,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00008,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,SIGMAR1: MAM calcium dysregulation | TUBA4A: Microtubule destabilization,MAM calcium dysregulation
AFR_00009,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00010,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00011,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00012,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00015,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00016,AFR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00017,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00018,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00019,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00020,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00021,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00022,AFR,3,VCP,7.7,Moderate,Slow Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00023,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00024,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00025,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00026,AFR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00027,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00028,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00030,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00031,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00032,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00033,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00034,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00035,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00036,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00037,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00038,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00039,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AFR_00040,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00041,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00042,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00043,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00044,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00045,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00046,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00047,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00048,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00049,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00051,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00052,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00053,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00054,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00055,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00056,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00057,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00058,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00059,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00060,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00061,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00062,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00063,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00064,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00065,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00066,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00067,AFR,2,SQSTM1,7.8,Moderate,Fast Progression,HNRNPA1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00068,AFR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AFR_00069,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00070,AFR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00071,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00072,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00073,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00074,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00075,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00076,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00077,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00078,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00079,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00080,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00082,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00083,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00084,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00085,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00086,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00087,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00088,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00089,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00090,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00091,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00092,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00093,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00094,AFR,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00095,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00097,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00098,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00101,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00102,AFR,2,KIF5A,6.6,Moderate,Slow Progression,DCTN1; KIF5A,0,0,,,0,0,,,1,2,DCTN1; KIF5A,DCTN1: Retrograde transport failure | KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00103,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00104,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00105,AFR,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00106,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00107,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00108,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00109,AFR,2,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00110,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00111,AFR,1,VCP,9.1,Severe,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00112,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00113,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_00114,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00116,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00117,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00118,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00119,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00120,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00121,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00122,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_00123,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00124,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00125,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00126,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00127,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00129,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00130,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00132,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00133,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00134,AFR,2,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00135,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00136,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Endosome-lysosome fusion failure
AFR_00137,AFR,2,FUS,9.9,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00138,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00139,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00140,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00141,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00142,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00143,AFR,2,OPTN,7.8,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00144,AFR,3,TBK1,10.0,Severe,Fast Progression,C9orf72; SIGMAR1; TBK1,1,2,C9ORF72; TBK1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,4,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00145,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00146,AFR,2,FIG4,9.2,Severe,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00147,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00148,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_00149,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00150,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00151,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00152,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00153,AFR,1,LOC130003372,6.6,Moderate,Asymptomatic/Low Penetrance,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00154,AFR,3,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00156,AFR,3,LOC108903148,9.2,Severe,Fast Progression,ALS2; FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_00157,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00158,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00159,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00160,AFR,2,TARDBP,7.0,Moderate,Slow Progression,ERBB4; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00161,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00162,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00163,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00165,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00166,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00167,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00168,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00169,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00171,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00172,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00174,AFR,2,OPTN,9.2,Severe,Slow Progression,OPTN; TUBA4A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | TUBA4A: Microtubule destabilization,Autophagy receptor dysfunction
AFR_00175,AFR,2,VCP,7.7,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00176,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00177,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00178,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00179,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00180,AFR,3,UBQLN2,7.7,Moderate,Slow Progression,TARDBP; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
AFR_00181,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00183,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00184,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00185,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00186,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00187,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00189,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00190,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00191,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00192,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00193,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00194,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00195,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00196,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00197,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00198,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00199,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00200,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00201,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00202,AFR,2,TBK1,9.8,Severe,Fast Progression,TBK1; UNC13A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UNC13A: Synaptic transmission defects,Autophagy initiation kinase deficiency
AFR_00203,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00204,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00205,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,KIF5A; LOC108903148,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Unknown mechanism
AFR_00206,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00207,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00208,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00209,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00210,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00211,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00212,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00215,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00216,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00217,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00218,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00219,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00220,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00221,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00222,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00224,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00225,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00226,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00227,AFR,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00228,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00229,AFR,2,TARDBP,7.0,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00230,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00231,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00232,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00233,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00234,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00235,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00236,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00237,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00238,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00240,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00242,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00243,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00244,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00245,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00246,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00247,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00248,AFR,3,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00249,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00250,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00251,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00252,AFR,2,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_00253,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00254,AFR,1,KIF5A,9.2,Severe,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00255,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00256,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00258,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00259,AFR,4,FUS,10.0,Severe,Fast Progression,FUS; HNRNPA2B1; SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FUS; HNRNPA2B1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00260,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00261,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00263,AFR,1,LOC108903148,6.6,Moderate,Asymptomatic/Low Penetrance,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00264,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00265,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00267,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00268,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00269,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00270,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00271,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00272,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00273,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_00274,AFR,2,TBK1,10.0,Severe,Fast Progression,LOC108903148; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00275,AFR,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_00276,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00277,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00278,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00279,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00280,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00282,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00284,AFR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_00285,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00287,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00289,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00290,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00291,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00293,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00294,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00296,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00297,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_00298,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00299,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00300,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00301,AFR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00302,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00303,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00304,AFR,4,TBK1,9.1,Severe,Fast Progression,ALS2; SQSTM1; TBK1; VCP,1,3,SQSTM1; TBK1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00305,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00306,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00307,AFR,3,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
AFR_00308,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00309,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00310,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00311,AFR,3,FIG4,8.4,Severe,Fast Progression,FIG4; LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00312,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00313,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00314,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00315,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00316,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00317,AFR,2,OPTN,7.8,Moderate,Slow Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_00318,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00319,AFR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00321,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00322,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00323,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00324,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00325,AFR,2,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00326,AFR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00327,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00329,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00330,AFR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00331,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00332,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00333,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00334,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00335,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00336,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00337,AFR,2,SPG11,7.0,Moderate,Slow Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00338,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00339,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00340,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00341,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00342,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00343,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00344,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00345,AFR,2,SPG11,7.0,Moderate,Fast Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_00346,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00347,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00348,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00349,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00350,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00351,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00352,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00353,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00354,AFR,3,LOC130001681,9.2,Severe,Fast Progression,ALS2; LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00355,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00356,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00357,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00358,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00359,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00360,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00363,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00364,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00365,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00366,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00367,AFR,1,OPTN,9.2,Severe,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00368,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00369,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00370,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00371,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00372,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00373,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00374,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00375,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00376,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00377,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00378,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00379,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00380,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00381,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00382,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00383,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00384,AFR,2,TUBA4A,6.0,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00385,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00386,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00388,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00389,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00390,AFR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AFR_00391,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00392,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00393,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00394,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00395,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00396,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00397,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00398,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00399,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00400,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00401,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00402,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00403,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00404,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00406,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00407,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00408,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00409,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00410,AFR,4,FUS,10.0,Severe,Fast Progression,FUS; OPTN; SIGMAR1; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00411,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00412,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Unknown mechanism
AFR_00413,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00415,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00416,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00417,AFR,5,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; SPG11; SQSTM1; TARDBP,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00418,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00420,AFR,2,KIF5A,7.8,Moderate,Fast Progression,KIF5A; SETX,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure | SETX: R-loop accumulation; genomic instability,Anterograde transport failure
AFR_00421,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00422,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00423,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00424,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00425,AFR,2,LOC108903148,9.2,Severe,Slow Progression,LOC108903148; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AFR_00426,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00427,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00428,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00429,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00430,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00431,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00432,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00433,AFR,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AFR_00434,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00435,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00436,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00437,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00438,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AFR_00439,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00440,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00441,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00442,AFR,2,TBK1,9.1,Severe,Fast Progression,KIF5A; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00443,AFR,2,SPG11,7.0,Moderate,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00444,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00445,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00446,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00447,AFR,2,TARDBP,7.0,Moderate,Slow Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00448,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00450,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00451,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00452,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00453,AFR,2,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
AFR_00454,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00455,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00457,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00458,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00459,AFR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
AFR_00460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00461,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00462,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00463,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00464,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00465,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00466,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00467,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00468,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00469,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00471,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00472,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00473,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00474,AFR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00475,AFR,1,LOC108903148,6.6,Moderate,Asymptomatic/Low Penetrance,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00476,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00477,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00478,AFR,2,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00479,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00481,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00482,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_00483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00484,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00485,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00486,AFR,1,SIGMAR1,7.7,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00487,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00488,AFR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00489,AFR,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00490,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00492,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00493,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00494,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00495,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00496,AFR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00497,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00498,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00499,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00500,AFR,2,FIG4,9.2,Severe,Fast Progression,FIG4; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Mitochondrial,FIG4: Lysosomal biogenesis failure | SIGMAR1: MAM calcium dysregulation,Lysosomal biogenesis failure
AFR_00501,AFR,3,SQSTM1,8.4,Severe,Fast Progression,SOD1; SPG11; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00502,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00503,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00504,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00505,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00506,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00507,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00508,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00509,AFR,2,VCP,7.7,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00510,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00511,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00512,AFR,2,FIG4,8.4,Severe,Fast Progression,ALS2; FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00513,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00514,AFR,2,VCP,7.7,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00515,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00516,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00517,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00518,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00519,AFR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00521,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00522,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00523,AFR,2,TBK1,9.1,Severe,Fast Progression,CHMP2B; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00524,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00525,AFR,3,SPG11,7.0,Moderate,Slow Progression,FUS; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00526,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00527,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00528,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00529,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00530,AFR,2,SETX,6.2,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,R-loop accumulation; genomic instability
AFR_00531,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00532,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00533,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00534,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00535,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00536,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00537,AFR,1,UBQLN2,7.7,Moderate,Fast Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00538,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00540,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SETX; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00542,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00544,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00545,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00546,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00547,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00549,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00550,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00552,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00553,AFR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00554,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00555,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00556,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00557,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00558,AFR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00559,AFR,5,TBK1,7.0,Moderate,Slow Progression,ALS2; SOD1; TBK1; UNC13A,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | UNC13A: Synaptic transmission defects,Autophagy initiation kinase deficiency
AFR_00560,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00561,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00562,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00563,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00564,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00567,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00568,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00569,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00571,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00572,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00573,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00574,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00575,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00576,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00577,AFR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00578,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_00579,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00580,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00581,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00582,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00583,AFR,2,SETX,5.2,Mild,Slow Progression,ERBB4; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00584,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00585,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00586,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00587,AFR,2,TBK1,9.8,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00588,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00590,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00591,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00592,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00593,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00594,AFR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00595,AFR,1,NEK1,9.2,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00596,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00597,AFR,1,SIGMAR1,5.0,Mild,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00598,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00600,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00601,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00602,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00603,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00605,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00607,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00608,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00610,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00611,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00612,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00613,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00614,AFR,3,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00615,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00616,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,ERBB4; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00617,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00618,AFR,4,VCP,9.1,Severe,Fast Progression,FUS; LOC130056973; TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00619,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00620,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00621,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00622,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00623,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00624,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00625,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00626,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00627,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00629,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00631,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00633,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00634,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00635,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00638,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00640,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00641,AFR,2,FUS,9.9,Severe,Slow Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00642,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00643,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00644,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_00645,AFR,2,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00646,AFR,2,SOD1,7.0,Moderate,Slow Progression,KIF5A; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00647,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00648,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00649,AFR,2,SOD1,7.0,Moderate,Fast Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00650,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00651,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00652,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00653,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00654,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00655,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00656,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00657,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00658,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00659,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00660,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00661,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00663,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00664,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00665,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00666,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00667,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AFR_00668,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00669,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00670,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00671,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00672,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00673,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00674,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00675,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00676,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00677,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00678,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_00679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00680,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00681,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00682,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00683,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00684,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00685,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00686,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00687,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00688,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00689,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00690,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00691,AFR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AFR_00692,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00694,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00695,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00696,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00698,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00699,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00700,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00701,AFR,4,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SQSTM1; TARDBP; UBQLN2,1,2,SQSTM1; UBQLN2,SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_00702,AFR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00703,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00704,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00705,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00707,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00708,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00709,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00710,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00711,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00712,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00713,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00714,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00715,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00717,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00718,AFR,1,UBQLN2,7.0,Moderate,Asymptomatic/Low Penetrance,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00719,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00720,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00721,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00722,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00723,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00724,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00725,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00727,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00728,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00729,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00730,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00731,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00732,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00733,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00734,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00735,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00736,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00738,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00739,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00740,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00741,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00742,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00743,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00744,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00745,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00746,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00747,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00748,AFR,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_00749,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00751,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00752,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00753,AFR,2,DCTN1,9.1,Severe,Slow Progression,DCTN1; SIGMAR1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SIGMAR1: MAM calcium dysregulation,Retrograde transport failure
AFR_00754,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00756,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00757,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00758,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00759,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00760,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00761,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00762,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00763,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00765,AFR,4,OPTN,8.4,Severe,Fast Progression,ERBB4; OPTN; SOD1; UBQLN2,1,3,OPTN; SOD1; UBQLN2,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_00766,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00768,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00769,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00770,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00771,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00772,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00773,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00774,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00775,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00776,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00777,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00778,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00779,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00780,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00781,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00782,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00783,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00784,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00785,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00786,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00787,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00788,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00789,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00790,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00791,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00792,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00793,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00795,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00796,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_00797,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00798,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00799,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00800,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00801,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00802,AFR,3,SPTLC1,6.9,Moderate,Fast Progression,OPTN; SPG11; SPTLC1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_00803,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00804,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00805,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00806,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00807,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00808,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00809,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00810,AFR,3,NEK1,8.4,Severe,Slow Progression,ALS2; NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AFR_00811,AFR,2,FUS,10.0,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00812,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00814,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00815,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00816,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00817,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00818,AFR,3,TARDBP,7.7,Moderate,Slow Progression,ALS2; ANXA11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00819,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00820,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00821,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00823,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00824,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00825,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00826,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00827,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00828,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00829,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00830,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00832,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00833,AFR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00834,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00835,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00836,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00837,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00838,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00839,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00840,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00841,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00842,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00843,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00844,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00845,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00846,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00847,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00848,AFR,2,SOD1,7.7,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00849,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00850,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00851,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00853,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00854,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00855,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00856,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00857,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00858,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00859,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00860,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00861,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00862,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00863,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00864,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00865,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00866,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00867,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00868,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00869,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00870,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00872,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00873,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00874,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00875,AFR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
AFR_00876,AFR,3,SOD1,7.0,Moderate,Slow Progression,CHCHD10; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,2,CHCHD10; SOD1,CHCHD10: Cristae disruption; mtDNA instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Mitochondrial,CHCHD10: Cristae disruption; mtDNA instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00877,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00878,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00879,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00880,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00881,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00882,AFR,2,SQSTM1,9.2,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00883,AFR,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00884,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00885,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00886,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00887,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00888,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00889,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00890,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00891,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00892,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00893,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00894,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00895,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00896,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00898,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00899,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00900,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00903,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00904,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00905,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00906,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00907,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00908,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00909,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00910,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00911,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00912,AFR,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Excitotoxicity,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00914,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00916,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00917,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00918,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00919,AFR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00920,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00921,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_00922,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00924,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00925,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00927,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_00928,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00929,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00930,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00931,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00933,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00935,AFR,2,FIG4,7.8,Moderate,Fast Progression,ALS2; FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00936,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00937,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00938,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00939,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00940,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00941,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00942,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00943,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00944,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00945,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00946,AFR,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00947,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00948,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00949,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00950,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00951,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00952,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00954,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00955,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00956,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00957,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00958,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00959,AFR,3,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_00960,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00962,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00964,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00965,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00966,AFR,2,SPTLC1,6.9,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00968,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00970,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00971,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00972,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00973,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00975,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00977,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00979,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00980,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00981,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00982,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00983,AFR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00984,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00985,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00986,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00988,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00989,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00990,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00991,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00992,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00993,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00994,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00995,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00996,AFR,2,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00997,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00998,AFR,2,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00999,AFR,4,TBK1,10.0,Severe,Fast Progression,SETX; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01002,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01003,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01005,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01006,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01007,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01008,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01009,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01010,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01011,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01012,AFR,3,VCP,7.7,Moderate,Slow Progression,ALS2; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01015,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; NEK1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01016,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01017,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01018,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01019,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01020,AFR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01021,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01022,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01023,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01024,AFR,2,SOD1,7.0,Moderate,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01025,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01026,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01027,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01028,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01030,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01031,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_01032,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01033,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01034,AFR,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01035,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01036,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01037,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01038,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01039,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01040,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01041,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01042,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01043,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01044,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01045,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01046,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01047,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01048,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01049,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01051,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01052,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01053,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01054,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01055,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01056,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01057,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01058,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01059,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01060,AFR,2,SOD1,7.7,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01061,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01062,AFR,3,VCP,7.7,Moderate,Slow Progression,CHMP2B; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01063,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01064,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01065,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01066,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01067,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01068,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01069,AFR,2,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01070,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01071,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01072,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01073,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01074,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01075,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01076,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01077,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01078,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01079,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01080,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01082,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01083,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01084,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01085,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01086,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01087,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01088,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SETX; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01089,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01090,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01091,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01092,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01093,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01094,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01095,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01097,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01098,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01101,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01102,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01103,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01104,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01105,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01106,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01107,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01108,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01109,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01110,AFR,2,SQSTM1,9.2,Severe,Fast Progression,CHMP2B; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01111,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01112,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01113,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01114,AFR,2,SYNE1,9.2,Severe,Fast Progression,SETX; SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AFR_01115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01116,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01117,AFR,2,TBK1,9.8,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01118,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01119,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01120,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01121,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01122,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01123,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01124,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01125,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01126,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01127,AFR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
AFR_01128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01129,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01130,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01132,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01133,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01134,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01135,AFR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01136,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01137,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01138,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01139,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01140,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01141,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01142,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01143,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01144,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01145,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01146,AFR,2,TBK1,9.1,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01147,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Lysosome reformation failure; DNA repair defects
AFR_01148,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01149,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01150,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01151,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01152,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01153,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01154,AFR,3,TARDBP,7.7,Moderate,Fast Progression,ALS2; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01156,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01157,AFR,4,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1; TBK1,1,3,OPTN; SOD1; TBK1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AFR_01158,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01159,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01160,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01161,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01162,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01163,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01165,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01166,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01167,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01168,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01169,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01171,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01172,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01174,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01175,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01176,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01177,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01178,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01179,AFR,2,SQSTM1,8.4,Severe,Fast Progression,DCTN1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01180,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01181,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01183,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01184,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01185,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01186,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01187,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01189,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01190,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01191,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01192,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_01193,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01194,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01195,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01196,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01197,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01198,AFR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01199,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01200,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01201,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01202,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01203,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01204,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01205,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01206,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01207,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01208,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01209,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01210,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01211,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01212,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01215,AFR,3,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01216,AFR,3,TUBA4A,6.0,Moderate,Slow Progression,NEK1; SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01217,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01218,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01219,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01220,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01221,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01222,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01224,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01225,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01226,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01227,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01228,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01229,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01230,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01231,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01232,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01233,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01234,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01235,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01236,AFR,2,SQSTM1,8.4,Severe,Fast Progression,ANG; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,ANG: Ribosomal biogenesis impairment | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01237,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01238,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01240,AFR,2,OPTN,8.4,Severe,Fast Progression,LOC130001681; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01242,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01243,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01244,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01245,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01246,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01247,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01248,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01249,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01250,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01251,AFR,2,PRPH,7.8,Moderate,Fast Progression,PRPH; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01252,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01253,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01254,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01255,AFR,3,ANXA11,8.6,Severe,Slow Progression,ANXA11; NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_01256,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01258,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01259,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01260,AFR,3,OPTN,7.8,Moderate,Fast Progression,OPTN; TBK1; UBQLN2,1,3,OPTN; TBK1; UBQLN2,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_01261,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01263,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_01264,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01265,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01267,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01268,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01269,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01270,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01271,AFR,1,SIGMAR1,7.7,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01272,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01273,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01274,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01275,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01276,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01277,AFR,3,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; TARDBP; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_01278,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01279,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01280,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01282,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01284,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01285,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01287,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01289,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01290,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01291,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01293,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01294,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01296,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01297,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01298,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01299,AFR,2,TBK1,9.8,Severe,Fast Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01300,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01301,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01302,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01303,AFR,2,TBK1,10.0,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01304,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01305,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01306,AFR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01307,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01308,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01309,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01310,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01311,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01312,AFR,2,VCP,7.7,Moderate,Slow Progression,LOC108903148; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01313,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01314,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01315,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01316,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01317,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01318,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01319,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01321,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01322,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01323,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01324,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01325,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01326,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01327,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01329,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01330,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01331,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01332,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01333,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01334,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01335,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01336,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01337,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01338,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01339,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; HNRNPA2B1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,2,FUS; HNRNPA2B1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01340,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01341,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01342,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01343,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01344,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01345,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01346,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01347,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01348,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01349,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01350,AFR,2,VCP,7.0,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01351,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01352,AFR,4,SOD1,7.0,Moderate,Slow Progression,FUS; SETX; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,3,FUS; SIGMAR1; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01353,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01354,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01355,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01356,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01357,AFR,2,TARDBP,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01358,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01359,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01360,AFR,3,SPG11,7.0,Moderate,Slow Progression,ALS2; SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01363,AFR,3,OPTN,7.8,Moderate,Fast Progression,OPTN; SIGMAR1; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01364,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01365,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01366,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01367,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01368,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01369,AFR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01370,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01371,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01372,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01373,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01374,AFR,2,TARDBP,7.7,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01375,AFR,4,SLC52A3,9.2,Severe,Fast Progression,HNRNPA2B1; SIGMAR1; SLC52A3; SPG11,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_01376,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01377,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01378,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01379,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01380,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01381,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Endosome-lysosome fusion failure
AFR_01382,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01383,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01384,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01385,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01386,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01388,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01389,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01390,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01391,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01392,AFR,2,LOC130001681,8.4,Severe,Fast Progression,ALS2; LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_01393,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01394,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01395,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01396,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01397,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01398,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01399,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01400,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01401,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01402,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01403,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01404,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01406,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01407,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01408,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01409,AFR,3,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01410,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01411,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01412,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01413,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01415,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01416,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01417,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01418,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01420,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01421,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01422,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_01423,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01424,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01425,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01426,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01427,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01428,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01429,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01430,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01431,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01432,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01433,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01434,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01435,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01436,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01437,AFR,3,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,3,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,DNA damage checkpoint failure
AFR_01438,AFR,2,SOD1,7.0,Moderate,Slow Progression,SCAF4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01439,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01440,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01441,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01442,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01443,AFR,2,NEK1,8.4,Severe,Slow Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01444,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01445,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01446,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01447,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01448,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01450,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01451,AFR,1,SIGMAR1,7.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01452,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
AFR_01453,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01454,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01455,AFR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01457,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01458,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01459,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01461,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01462,AFR,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01463,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01464,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01465,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01466,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01467,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01468,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01469,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01471,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01472,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01473,AFR,4,SQSTM1,7.8,Moderate,Fast Progression,ALS2; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01474,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01475,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01476,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01477,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01478,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01479,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01481,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01482,AFR,3,ALS2,7.0,Moderate,Slow Progression,ALS2; ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01484,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01485,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01486,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01487,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01488,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01489,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01490,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01492,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01493,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01494,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01495,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01496,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01497,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01498,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01499,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01500,AFR,2,SQSTM1,8.4,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction (p62)
AFR_01501,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01502,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01503,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01504,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01505,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01506,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01507,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01508,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01509,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01510,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01511,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01512,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01513,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01514,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01515,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01516,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01517,AFR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SLC52A3,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01518,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01519,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01521,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01522,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01523,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01524,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01525,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01526,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01527,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01528,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01529,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AFR_01530,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01531,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01532,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01533,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01534,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01535,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01536,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01537,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01538,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01540,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01542,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01544,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01545,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01546,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01547,AFR,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01549,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01550,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01552,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01553,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01554,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01555,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01556,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01557,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01558,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01559,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01560,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01561,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01562,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01563,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01564,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01567,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01568,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01569,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01571,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01572,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01573,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01574,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01575,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01576,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01577,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01578,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01579,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01580,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01581,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01582,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01583,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01584,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01585,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01586,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01587,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01588,AFR,2,FUS,9.0,Severe,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01590,AFR,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01591,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01592,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01593,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01594,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01595,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01596,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01597,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01598,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01600,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01601,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01602,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01603,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01605,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01607,AFR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01608,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01610,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01611,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01612,AFR,3,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1; VCP,1,3,SQSTM1; TBK1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_01613,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01614,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01615,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01616,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01617,AFR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_01618,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01619,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01620,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01621,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01622,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01623,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01624,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01625,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01626,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01627,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01629,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01631,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01633,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01634,AFR,2,SOD1,7.0,Moderate,Fast Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01635,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01638,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01640,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01641,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01642,AFR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01643,AFR,1,NEK1,7.8,Moderate,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01644,AFR,2,SPG11,7.0,Moderate,Slow Progression,SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01645,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01646,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01647,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01648,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01649,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01650,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01651,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01652,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01653,AFR,2,SETX,5.2,Mild,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01654,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01655,AFR,3,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01656,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01657,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01658,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01659,AFR,3,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01660,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01661,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01663,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01664,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01665,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SETX; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Mitochondrial,SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01666,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01667,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01668,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01669,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01670,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01671,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01672,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01673,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01674,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01675,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01676,AFR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01677,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01678,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01680,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01681,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01682,AFR,2,OPTN,9.2,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01683,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01684,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01685,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01686,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Endosome-lysosome fusion failure
AFR_01687,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01688,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01689,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01690,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01691,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01692,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01694,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01695,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01696,AFR,3,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01698,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01699,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01700,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01701,AFR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01702,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01703,AFR,2,TARDBP,7.7,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01704,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01705,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01707,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01708,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01709,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01710,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01711,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01712,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01713,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01714,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01715,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01717,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01718,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01719,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_01720,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01721,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01722,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01723,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01724,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01725,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01727,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01728,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01729,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01730,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01731,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01732,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01733,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01734,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01735,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01736,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01738,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01739,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01740,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01741,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01742,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01743,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01744,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01745,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01746,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01747,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01748,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01749,AFR,2,TBK1,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01751,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01752,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01753,AFR,2,UBQLN2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01754,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01756,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01757,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01758,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01759,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01760,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01761,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01762,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_01763,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01765,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01766,AFR,3,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
AFR_01767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01768,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01769,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01770,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01771,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01772,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01773,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01774,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01775,AFR,2,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01776,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01777,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Endosome-lysosome fusion failure
AFR_01778,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01779,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01780,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01781,AFR,1,UBQLN2,7.0,Moderate,Asymptomatic/Low Penetrance,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01782,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01783,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01784,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01785,AFR,3,TBK1,9.1,Severe,Fast Progression,OPTN; SIGMAR1; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01786,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01787,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01788,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01789,AFR,4,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01790,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01791,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01792,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01793,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01795,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01796,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01797,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01798,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01799,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01800,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01801,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01802,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01803,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01804,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01805,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01806,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01807,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01808,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01809,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01810,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01811,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01812,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01814,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01815,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01816,AFR,2,SQSTM1,9.2,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01817,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01818,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01819,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01820,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01821,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01823,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01824,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01825,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01826,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01827,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01828,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01829,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01830,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01832,AFR,2,TBK1,9.1,Severe,Fast Progression,CHMP2B; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01833,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01834,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01835,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01836,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01837,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01838,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01839,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01840,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01841,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01842,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01843,AFR,2,SQSTM1,8.4,Severe,Fast Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01844,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01845,AFR,2,TBK1,7.0,Moderate,Slow Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01846,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01847,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01848,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01849,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01850,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01851,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AFR_01852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01853,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01854,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01855,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01856,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01857,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01858,AFR,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01859,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01860,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01861,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01862,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01863,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01864,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01865,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,SIGMAR1: MAM calcium dysregulation | TUBA4A: Microtubule destabilization,MAM calcium dysregulation
AFR_01866,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01867,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01868,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01869,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01870,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01872,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01873,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01874,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01875,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01876,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01877,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01878,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01879,AFR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01880,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01881,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01882,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01883,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01884,AFR,3,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Excitotoxicity,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01885,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01886,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01887,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01888,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01889,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01890,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01891,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01892,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01893,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01894,AFR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01895,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01896,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01898,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01899,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01900,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01903,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01904,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01905,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01906,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01907,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01908,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01909,AFR,2,VCP,7.7,Moderate,Slow Progression,TUBA4A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TUBA4A: Microtubule destabilization | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01910,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01911,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01912,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01914,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01916,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01917,AFR,4,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1; UNC13A,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction
AFR_01918,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01919,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01920,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01921,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01922,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01924,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01925,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01927,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01928,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01929,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01930,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01931,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01933,AFR,2,TBK1,9.8,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01935,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01936,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01937,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01938,AFR,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01939,AFR,2,VCP,7.0,Moderate,Slow Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01940,AFR,3,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01941,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01942,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01943,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01944,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01945,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01946,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01947,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_01948,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01949,AFR,2,TBK1,7.0,Moderate,Slow Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01950,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_01951,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01952,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01954,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01955,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01956,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01957,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01958,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01959,AFR,2,VCP,7.0,Moderate,Slow Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01960,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01962,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01964,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01965,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01966,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01968,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01970,AFR,2,FUS,10.0,Severe,Fast Progression,FIG4; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01971,AFR,3,FUS,9.9,Severe,Slow Progression,DCTN1; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,5,Mitochondrial,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01972,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01973,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01975,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01977,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01979,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01980,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01981,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01982,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01983,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01984,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01985,AFR,5,VCP,7.0,Moderate,Slow Progression,ALS2; CHRNA3; SETX; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01986,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01988,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01989,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_01990,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01991,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01992,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01993,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01994,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01995,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01996,AFR,2,TBK1,9.1,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01997,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01998,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01999,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02002,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02003,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02005,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02006,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02007,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02008,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02009,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02010,AFR,2,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02011,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02012,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02015,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02016,AFR,2,SOD1,7.0,Moderate,Slow Progression,KIF5A; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02017,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02018,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02019,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02020,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02021,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02022,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02023,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02024,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02025,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02026,AFR,2,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02027,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02028,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02030,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02031,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02032,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02033,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02034,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02035,AFR,1,SOD1,7.7,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02036,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02037,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02038,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02039,AFR,1,SPG11,6.5,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02040,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02041,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02042,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02043,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02044,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02045,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02046,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02047,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02048,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02049,AFR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_02050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02051,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02052,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02053,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02054,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02055,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02056,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02057,AFR,4,SPG11,7.0,Moderate,Slow Progression,OPTN; SETX; SOD1; SPG11,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02058,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02059,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02060,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02061,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02062,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02063,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02064,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02065,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02066,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02067,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02068,AFR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02069,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02070,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02071,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02072,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02073,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02074,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02075,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02076,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02077,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_02078,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02079,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02080,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02082,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02083,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02084,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02085,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02086,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02087,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02088,AFR,3,NEK1,8.4,Severe,Fast Progression,NEK1; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,3,DNA_Damage,NEK1: DNA damage checkpoint failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AFR_02089,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02090,AFR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_02091,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02092,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02093,AFR,2,NEK1,8.4,Severe,Fast Progression,NEK1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,DNA damage checkpoint failure
AFR_02094,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02095,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02097,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02098,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02101,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02102,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02103,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02104,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02105,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02106,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02107,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02108,AFR,2,OPTN,7.8,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02109,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02110,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02111,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02112,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02113,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SLC52A3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02114,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02116,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02117,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02118,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02119,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02120,AFR,4,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AFR_02121,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02122,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02123,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02124,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02125,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02126,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02127,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02129,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02130,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02132,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02133,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02134,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02135,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02136,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02137,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02138,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02139,AFR,3,FIG4,8.4,Severe,Fast Progression,FIG4; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_02140,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02141,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02142,AFR,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02143,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02144,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02145,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02146,AFR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02147,AFR,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02148,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02149,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02150,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02151,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02152,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02153,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02154,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02156,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02157,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02158,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02159,AFR,1,ALS2,6.3,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02160,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02161,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02162,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_02163,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02165,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02166,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02167,AFR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02168,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02169,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02171,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02172,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02174,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02175,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02176,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02177,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02178,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02179,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02180,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02181,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02183,AFR,2,SOD1,7.7,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02184,AFR,2,C9orf72,8.8,Severe,Slow Progression,C9orf72; SOD1,1,2,C9ORF72; SOD1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,C9ORF72; SOD1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_02185,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02186,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02187,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02189,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02190,AFR,2,FUS,9.0,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02191,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02192,AFR,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02193,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02194,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02195,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02196,AFR,2,TBK1,9.1,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02197,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02198,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02199,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02200,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02201,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02202,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02203,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02204,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02205,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02206,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02207,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02208,AFR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02209,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02210,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02211,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02212,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02215,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02216,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02217,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02218,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02219,AFR,2,VCP,7.7,Moderate,Slow Progression,UNC13A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,UNC13A: Synaptic transmission defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02220,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02221,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02222,AFR,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02224,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02225,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02226,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02227,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02228,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02229,AFR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02230,AFR,2,VCP,7.7,Moderate,Slow Progression,CHMP2B; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02231,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02232,AFR,3,TBK1,9.8,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02233,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02234,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02235,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02236,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02237,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02238,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02240,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02242,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02243,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02244,AFR,3,ALS2,6.5,Moderate,Slow Progression,ALS2; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_02245,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02246,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02247,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02248,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02249,AFR,3,VCP,7.7,Moderate,Slow Progression,ALS2; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02250,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02251,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02252,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02253,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02254,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02255,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02256,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02258,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02259,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02260,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02261,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02263,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; HNRNPA1,0,0,,,1,2,FUS; HNRNPA1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02264,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02265,AFR,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02267,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02268,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02269,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02270,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02271,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02272,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02273,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02274,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02275,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02276,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02277,AFR,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02278,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02279,AFR,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02280,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02282,AFR,1,NEK1,9.2,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02284,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02285,AFR,3,SQSTM1,9.2,Severe,Fast Progression,SETX; SLC52A3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02287,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02289,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02290,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02291,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02293,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02294,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02296,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02297,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02298,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02299,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02300,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02301,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02302,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02303,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02304,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02305,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02306,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02307,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02308,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02309,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02310,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02311,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02312,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02313,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02314,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02315,AFR,2,TARDBP,7.0,Moderate,Fast Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02316,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02317,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02318,AFR,2,SQSTM1,9.2,Severe,Fast Progression,NEK1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02319,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02321,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02322,AFR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02323,AFR,1,PLEKHG5,6.2,Moderate,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02324,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02325,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02326,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02327,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02329,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02330,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02331,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02332,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,DCTN1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02333,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02334,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02335,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02336,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02337,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02338,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02339,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AFR_02340,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02341,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02342,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02343,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02344,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02345,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02346,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02347,AFR,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02348,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02349,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02350,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02351,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02352,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02353,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02354,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02355,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02356,AFR,1,ANXA11,8.6,Severe,Slow Progression,ANXA11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02357,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02358,AFR,2,ALS2,7.2,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AFR_02359,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02360,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02363,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02364,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02365,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02366,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02367,AFR,3,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02368,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02369,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02370,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02371,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02372,AFR,2,TBK1,7.0,Moderate,Slow Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02373,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02374,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02375,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02376,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02377,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02378,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02379,AFR,2,TBK1,9.1,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02380,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02381,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02382,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02383,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02384,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02385,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02386,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02388,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02389,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02390,AFR,3,SPG11,7.0,Moderate,Fast Progression,ALS2; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02391,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02392,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02393,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02394,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02395,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02396,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_02397,AFR,3,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02398,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02399,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02400,AFR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02401,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02402,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_02403,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02404,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02406,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02407,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02408,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02409,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02410,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02411,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02412,AFR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; HNRNPA1; TARDBP,0,0,,,1,2,HNRNPA1; TARDBP,HNRNPA1: Stress granule dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | HNRNPA1: Stress granule dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosomal biogenesis failure
AFR_02413,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02415,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02416,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02417,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02418,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02420,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02421,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
AFR_02422,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02423,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02424,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02425,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02426,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02427,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02428,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02429,AFR,2,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02430,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02431,AFR,1,FIG4,7.8,Moderate,Asymptomatic/Low Penetrance,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02432,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02433,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02434,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02435,AFR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02436,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02437,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02438,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02439,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02440,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02441,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02442,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02443,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02444,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02445,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02446,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02447,AFR,3,SQSTM1,8.4,Severe,Fast Progression,FUS; SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02448,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02450,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02451,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02452,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02453,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02454,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02455,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02457,AFR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02458,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02459,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02461,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02462,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02463,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02464,AFR,3,SOD1,9.8,Severe,Fast Progression,SLC52A3; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02465,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02466,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02467,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02468,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02469,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02471,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SPTLC1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02472,AFR,3,OPTN,9.2,Severe,Slow Progression,OPTN; SETX; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_02473,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02474,AFR,2,OPTN,6.0,Moderate,Slow Progression,ERBB4; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02475,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02476,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02477,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02478,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02479,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02481,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02482,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02484,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02485,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02486,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02487,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_02488,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02489,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02490,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02492,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02493,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02494,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02495,AFR,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA2B1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02496,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02497,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02498,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02499,AFR,1,TARDBP,7.7,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02500,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02501,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02502,AFR,2,LOC130001681,8.4,Severe,Fast Progression,LOC130001681; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
AFR_02503,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02504,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02505,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02506,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02507,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02508,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02509,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02510,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02511,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02512,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02513,AFR,2,SOD1,9.8,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02514,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02515,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02516,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02517,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02518,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02519,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02521,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02522,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02523,AFR,3,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
AFR_02524,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02525,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02526,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02527,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_02528,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02529,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02530,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02531,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02532,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02533,AFR,3,VCP,7.7,Moderate,Slow Progression,SIGMAR1; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02534,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02535,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02536,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02537,AFR,3,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02538,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02540,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02542,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02544,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02545,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Mitochondrial,FIG4: Lysosomal biogenesis failure | SIGMAR1: MAM calcium dysregulation,Lysosomal biogenesis failure
AFR_02546,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02547,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02549,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02550,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02552,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02553,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02554,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02555,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02556,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02557,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02558,AFR,2,SOD1,7.7,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02559,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02560,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02561,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02562,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02563,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02564,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02567,AFR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02568,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02569,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02571,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02572,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02573,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02574,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02575,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02576,AFR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02577,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02578,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02579,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02580,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02581,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02582,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_02583,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02584,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02585,AFR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02586,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02587,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02588,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02590,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02591,AFR,3,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02592,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02593,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02594,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02595,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02596,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02597,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02598,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02600,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02601,AFR,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02602,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02603,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02605,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02607,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02608,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02610,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02611,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02612,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02613,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02614,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02615,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02616,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02617,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02618,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02619,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02620,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02621,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02622,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02623,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02624,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02625,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02626,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02627,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02629,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02631,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02633,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02634,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02635,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02638,AFR,1,SPG11,6.5,Moderate,Asymptomatic/Low Penetrance,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02640,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02641,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02642,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02643,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02644,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02645,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02646,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02647,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02648,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02649,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02650,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02651,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02652,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02653,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02654,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02655,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02656,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02657,AFR,3,TBK1,10.0,Severe,Fast Progression,SOD1; TARDBP; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02658,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02659,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02660,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02661,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02663,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02664,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02665,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02666,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02667,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02668,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02669,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02670,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02671,AFR,2,OPTN,8.4,Severe,Fast Progression,C9orf72; OPTN,1,2,C9ORF72; OPTN,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | OPTN: Autophagy receptor dysfunction,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02672,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02673,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02674,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02675,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02676,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02677,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02678,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02680,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02681,AFR,2,SETX,6.2,Moderate,Slow Progression,DCTN1; SETX,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02682,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02683,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02684,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02685,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02686,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02687,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02688,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02689,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02690,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02691,AFR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02692,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02694,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02695,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02696,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02698,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02699,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02700,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02701,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02702,AFR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02703,AFR,3,ALS2,6.5,Moderate,Slow Progression,ALS2; ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_02704,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02705,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02707,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02708,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_02709,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02710,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02711,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02712,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02713,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02714,AFR,2,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_02715,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02717,AFR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02718,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02719,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02720,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02721,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02722,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02723,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02724,AFR,2,CHRNA3,8.4,Severe,Fast Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02725,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02727,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02728,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02729,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02730,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02731,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02732,AFR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02733,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02734,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02735,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02736,AFR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02738,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02739,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02740,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02741,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02742,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02743,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02744,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02745,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02746,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02747,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02748,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02749,AFR,2,LOC124629354,8.4,Severe,Fast Progression,ALS2; LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02751,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02752,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02753,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02754,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02756,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02757,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02758,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AFR_02759,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02760,AFR,2,ALS2,7.2,Moderate,Slow Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Endosome-lysosome fusion failure
AFR_02761,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02762,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02763,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02765,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02766,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02768,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02769,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02770,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02771,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02772,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02773,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02774,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02775,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02776,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02777,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02778,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02779,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02780,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02781,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02782,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02783,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02784,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02785,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02786,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02787,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02788,AFR,2,SLC52A3,9.2,Severe,Fast Progression,PLEKHG5; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02789,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02790,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_02791,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02792,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02793,AFR,2,SQSTM1,8.6,Severe,Slow Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02795,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02796,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02797,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02798,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02799,AFR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02800,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02801,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02802,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02803,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_02804,AFR,2,SOD1,7.0,Moderate,Slow Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02805,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02806,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02807,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02808,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02809,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02810,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02811,AFR,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_02812,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02814,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02815,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02816,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02817,AFR,3,SOD1,7.7,Moderate,Slow Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02818,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02819,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02820,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02821,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02823,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02824,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02825,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02826,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02827,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02828,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02829,AFR,2,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02830,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02832,AFR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02833,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02834,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02835,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02836,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02837,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02838,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02839,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02840,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02841,AFR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02842,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02843,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02844,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02845,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02846,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02847,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02848,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02849,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02850,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02851,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02853,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02854,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02855,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02856,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02857,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02858,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_02859,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02860,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02861,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02862,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02863,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02864,AFR,1,TBK1,7.7,Moderate,Asymptomatic/Low Penetrance,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02865,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02866,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02867,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02868,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02869,AFR,1,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_02870,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02872,AFR,3,OPTN,7.8,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_02873,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02874,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02875,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02876,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02877,AFR,3,SOD1,7.7,Moderate,Fast Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02878,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02879,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02880,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02881,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02882,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02883,AFR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02884,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02885,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02886,AFR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02887,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02888,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02889,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02890,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02891,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02892,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02893,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02894,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02895,AFR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02896,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02898,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02899,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02900,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_02901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02903,AFR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02904,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02905,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02906,AFR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02907,AFR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02908,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02909,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02910,AFR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02911,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02912,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02914,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02916,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_02917,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02918,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02919,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02920,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02921,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02922,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02924,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02925,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02927,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02928,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02929,AFR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AFR_02930,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02931,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02933,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02935,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02936,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02937,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02938,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02939,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02940,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02941,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02942,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02943,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02944,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02945,AFR,2,TARDBP,7.0,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02946,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02947,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02948,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02949,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02950,AFR,3,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,Lysosome reformation failure; DNA repair defects
AFR_02951,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02952,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02954,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02955,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02956,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; TBK1; VCP,1,3,SOD1; TBK1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02957,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02958,AFR,2,SOD1,7.0,Moderate,Fast Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02959,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02960,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02962,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02964,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02965,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02966,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02968,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02970,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
AFR_02971,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02972,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02973,AFR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_02974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02975,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AFR_02976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02977,AFR,4,NEK1,9.2,Severe,Fast Progression,NEK1; SOD1; SPG11; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,DNA damage checkpoint failure
AFR_02978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02979,AFR,3,LOC124629354,8.4,Severe,Fast Progression,DCTN1; FUS; LOC124629354,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_02980,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02981,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02982,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02983,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02984,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02985,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02986,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02988,AFR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02989,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02990,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02991,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02992,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02993,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02994,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02995,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02996,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02997,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02998,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02999,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
